ArticleFrontiers in pharmacology2026

Comparative safety profiles of risankizumab versus guselkumab: a pharmacovigilance study based on the FAERS database.

Shiyi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.